Figure 2: SARS-CoV monoclonal antibodies have marginal efficacy against SARS-like CoVs.
From: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
From: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence